Global Hereditary Angioedema Therapeutic Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-hereditary-angioedema-therapeutic-market-research-report-2024status-n-outlook_en.gif)
Report Overview:
Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.
The Global Hereditary Angioedema Therapeutic Market Size was estimated at USD 2268.19 million in 2023 and is projected to reach USD 3057.01 million by 2029, exhibiting a CAGR of 5.10% during the forecast period.
This report provides a deep insight into the global Hereditary Angioedema Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Therapeutic market in any manner.
Global Hereditary Angioedema Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Market Segmentation (by Type)
Intravenous
Subcutaneous
Oral
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.
The Global Hereditary Angioedema Therapeutic Market Size was estimated at USD 2268.19 million in 2023 and is projected to reach USD 3057.01 million by 2029, exhibiting a CAGR of 5.10% during the forecast period.
This report provides a deep insight into the global Hereditary Angioedema Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Therapeutic market in any manner.
Global Hereditary Angioedema Therapeutic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Market Segmentation (by Type)
Intravenous
Subcutaneous
Oral
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hereditary Angioedema Therapeutic Market
- Overview of the regional outlook of the Hereditary Angioedema Therapeutic Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Therapeutic
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Therapeutic Segment by Type
1.2.2 Hereditary Angioedema Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hereditary Angioedema Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Hereditary Angioedema Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hereditary Angioedema Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hereditary Angioedema Therapeutic Sales Sites, Area Served, Product Type
3.6 Hereditary Angioedema Therapeutic Market Competitive Situation and Trends
3.6.1 Hereditary Angioedema Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hereditary Angioedema Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global Hereditary Angioedema Therapeutic Price by Type (2019-2024)
7 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Therapeutic Market Sales by Application (2019-2024)
7.3 Global Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2024)
8 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Hereditary Angioedema Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hereditary Angioedema Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hereditary Angioedema Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hereditary Angioedema Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 BioCryst Pharma
9.1.1 BioCryst Pharma Hereditary Angioedema Therapeutic Basic Information
9.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
9.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.1.4 BioCryst Pharma Business Overview
9.1.5 BioCryst Pharma Hereditary Angioedema Therapeutic SWOT Analysis
9.1.6 BioCryst Pharma Recent Developments
9.2 Ionis Pharma
9.2.1 Ionis Pharma Hereditary Angioedema Therapeutic Basic Information
9.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
9.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.2.4 Ionis Pharma Business Overview
9.2.5 Ionis Pharma Hereditary Angioedema Therapeutic SWOT Analysis
9.2.6 Ionis Pharma Recent Developments
9.3 Pharming Group
9.3.1 Pharming Group Hereditary Angioedema Therapeutic Basic Information
9.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Overview
9.3.3 Pharming Group Hereditary Angioedema Therapeutic Product Market Performance
9.3.4 Pharming Group Hereditary Angioedema Therapeutic SWOT Analysis
9.3.5 Pharming Group Business Overview
9.3.6 Pharming Group Recent Developments
9.4 CSL Limited
9.4.1 CSL Limited Hereditary Angioedema Therapeutic Basic Information
9.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Overview
9.4.3 CSL Limited Hereditary Angioedema Therapeutic Product Market Performance
9.4.4 CSL Limited Business Overview
9.4.5 CSL Limited Recent Developments
9.5 Shire
9.5.1 Shire Hereditary Angioedema Therapeutic Basic Information
9.5.2 Shire Hereditary Angioedema Therapeutic Product Overview
9.5.3 Shire Hereditary Angioedema Therapeutic Product Market Performance
9.5.4 Shire Business Overview
9.5.5 Shire Recent Developments
9.6 Attune Pharma
9.6.1 Attune Pharma Hereditary Angioedema Therapeutic Basic Information
9.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Overview
9.6.3 Attune Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.6.4 Attune Pharma Business Overview
9.6.5 Attune Pharma Recent Developments
9.7 Adverum Biotechnologies
9.7.1 Adverum Biotechnologies Hereditary Angioedema Therapeutic Basic Information
9.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
9.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Market Performance
9.7.4 Adverum Biotechnologies Business Overview
9.7.5 Adverum Biotechnologies Recent Developments
9.8 KalVista Pharma
9.8.1 KalVista Pharma Hereditary Angioedema Therapeutic Basic Information
9.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
9.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.8.4 KalVista Pharma Business Overview
9.8.5 KalVista Pharma Recent Developments
10 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global Hereditary Angioedema Therapeutic Market Size Forecast
10.2 Global Hereditary Angioedema Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region
10.2.4 South America Hereditary Angioedema Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hereditary Angioedema Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hereditary Angioedema Therapeutic by Type (2025-2030)
11.1.2 Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hereditary Angioedema Therapeutic by Type (2025-2030)
11.2 Global Hereditary Angioedema Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global Hereditary Angioedema Therapeutic Sales (Kilotons) Forecast by Application
11.2.2 Global Hereditary Angioedema Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Therapeutic
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Therapeutic Segment by Type
1.2.2 Hereditary Angioedema Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hereditary Angioedema Therapeutic Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Global Hereditary Angioedema Therapeutic Sales by Manufacturers (2019-2024)
3.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Manufacturers (2019-2024)
3.3 Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hereditary Angioedema Therapeutic Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hereditary Angioedema Therapeutic Sales Sites, Area Served, Product Type
3.6 Hereditary Angioedema Therapeutic Market Competitive Situation and Trends
3.6.1 Hereditary Angioedema Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hereditary Angioedema Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2019-2024)
6.3 Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2019-2024)
6.4 Global Hereditary Angioedema Therapeutic Price by Type (2019-2024)
7 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Therapeutic Market Sales by Application (2019-2024)
7.3 Global Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2019-2024)
7.4 Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2024)
8 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY REGION
8.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Hereditary Angioedema Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hereditary Angioedema Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hereditary Angioedema Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hereditary Angioedema Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 BioCryst Pharma
9.1.1 BioCryst Pharma Hereditary Angioedema Therapeutic Basic Information
9.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
9.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.1.4 BioCryst Pharma Business Overview
9.1.5 BioCryst Pharma Hereditary Angioedema Therapeutic SWOT Analysis
9.1.6 BioCryst Pharma Recent Developments
9.2 Ionis Pharma
9.2.1 Ionis Pharma Hereditary Angioedema Therapeutic Basic Information
9.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
9.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.2.4 Ionis Pharma Business Overview
9.2.5 Ionis Pharma Hereditary Angioedema Therapeutic SWOT Analysis
9.2.6 Ionis Pharma Recent Developments
9.3 Pharming Group
9.3.1 Pharming Group Hereditary Angioedema Therapeutic Basic Information
9.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Overview
9.3.3 Pharming Group Hereditary Angioedema Therapeutic Product Market Performance
9.3.4 Pharming Group Hereditary Angioedema Therapeutic SWOT Analysis
9.3.5 Pharming Group Business Overview
9.3.6 Pharming Group Recent Developments
9.4 CSL Limited
9.4.1 CSL Limited Hereditary Angioedema Therapeutic Basic Information
9.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Overview
9.4.3 CSL Limited Hereditary Angioedema Therapeutic Product Market Performance
9.4.4 CSL Limited Business Overview
9.4.5 CSL Limited Recent Developments
9.5 Shire
9.5.1 Shire Hereditary Angioedema Therapeutic Basic Information
9.5.2 Shire Hereditary Angioedema Therapeutic Product Overview
9.5.3 Shire Hereditary Angioedema Therapeutic Product Market Performance
9.5.4 Shire Business Overview
9.5.5 Shire Recent Developments
9.6 Attune Pharma
9.6.1 Attune Pharma Hereditary Angioedema Therapeutic Basic Information
9.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Overview
9.6.3 Attune Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.6.4 Attune Pharma Business Overview
9.6.5 Attune Pharma Recent Developments
9.7 Adverum Biotechnologies
9.7.1 Adverum Biotechnologies Hereditary Angioedema Therapeutic Basic Information
9.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
9.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Market Performance
9.7.4 Adverum Biotechnologies Business Overview
9.7.5 Adverum Biotechnologies Recent Developments
9.8 KalVista Pharma
9.8.1 KalVista Pharma Hereditary Angioedema Therapeutic Basic Information
9.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
9.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Product Market Performance
9.8.4 KalVista Pharma Business Overview
9.8.5 KalVista Pharma Recent Developments
10 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET FORECAST BY REGION
10.1 Global Hereditary Angioedema Therapeutic Market Size Forecast
10.2 Global Hereditary Angioedema Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region
10.2.4 South America Hereditary Angioedema Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hereditary Angioedema Therapeutic by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hereditary Angioedema Therapeutic by Type (2025-2030)
11.1.2 Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hereditary Angioedema Therapeutic by Type (2025-2030)
11.2 Global Hereditary Angioedema Therapeutic Market Forecast by Application (2025-2030)
11.2.1 Global Hereditary Angioedema Therapeutic Sales (Kilotons) Forecast by Application
11.2.2 Global Hereditary Angioedema Therapeutic Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Therapeutic Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hereditary Angioedema Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hereditary Angioedema Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2022)
Table 10. Global Market Hereditary Angioedema Therapeutic Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hereditary Angioedema Therapeutic Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Therapeutic Product Type
Table 13. Global Hereditary Angioedema Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hereditary Angioedema Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Therapeutic Market Challenges
Table 22. Global Hereditary Angioedema Therapeutic Sales by Type (Kilotons)
Table 23. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 24. Global Hereditary Angioedema Therapeutic Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global Hereditary Angioedema Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global Hereditary Angioedema Therapeutic Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hereditary Angioedema Therapeutic Sales (Kilotons) by Application
Table 30. Global Hereditary Angioedema Therapeutic Market Size by Application
Table 31. Global Hereditary Angioedema Therapeutic Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global Hereditary Angioedema Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global Hereditary Angioedema Therapeutic Market Share by Application (2019-2024)
Table 35. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global Hereditary Angioedema Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America Hereditary Angioedema Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hereditary Angioedema Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hereditary Angioedema Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hereditary Angioedema Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 43. BioCryst Pharma Hereditary Angioedema Therapeutic Basic Information
Table 44. BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
Table 45. BioCryst Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. BioCryst Pharma Business Overview
Table 47. BioCryst Pharma Hereditary Angioedema Therapeutic SWOT Analysis
Table 48. BioCryst Pharma Recent Developments
Table 49. Ionis Pharma Hereditary Angioedema Therapeutic Basic Information
Table 50. Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
Table 51. Ionis Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ionis Pharma Business Overview
Table 53. Ionis Pharma Hereditary Angioedema Therapeutic SWOT Analysis
Table 54. Ionis Pharma Recent Developments
Table 55. Pharming Group Hereditary Angioedema Therapeutic Basic Information
Table 56. Pharming Group Hereditary Angioedema Therapeutic Product Overview
Table 57. Pharming Group Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pharming Group Hereditary Angioedema Therapeutic SWOT Analysis
Table 59. Pharming Group Business Overview
Table 60. Pharming Group Recent Developments
Table 61. CSL Limited Hereditary Angioedema Therapeutic Basic Information
Table 62. CSL Limited Hereditary Angioedema Therapeutic Product Overview
Table 63. CSL Limited Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. CSL Limited Business Overview
Table 65. CSL Limited Recent Developments
Table 66. Shire Hereditary Angioedema Therapeutic Basic Information
Table 67. Shire Hereditary Angioedema Therapeutic Product Overview
Table 68. Shire Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Shire Business Overview
Table 70. Shire Recent Developments
Table 71. Attune Pharma Hereditary Angioedema Therapeutic Basic Information
Table 72. Attune Pharma Hereditary Angioedema Therapeutic Product Overview
Table 73. Attune Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Attune Pharma Business Overview
Table 75. Attune Pharma Recent Developments
Table 76. Adverum Biotechnologies Hereditary Angioedema Therapeutic Basic Information
Table 77. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
Table 78. Adverum Biotechnologies Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Adverum Biotechnologies Business Overview
Table 80. Adverum Biotechnologies Recent Developments
Table 81. KalVista Pharma Hereditary Angioedema Therapeutic Basic Information
Table 82. KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
Table 83. KalVista Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. KalVista Pharma Business Overview
Table 85. KalVista Pharma Recent Developments
Table 86. Global Hereditary Angioedema Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Hereditary Angioedema Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Hereditary Angioedema Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Hereditary Angioedema Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Hereditary Angioedema Therapeutic Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Hereditary Angioedema Therapeutic Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Hereditary Angioedema Therapeutic Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Therapeutic Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Therapeutic Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Hereditary Angioedema Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hereditary Angioedema Therapeutic Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2022)
Table 10. Global Market Hereditary Angioedema Therapeutic Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hereditary Angioedema Therapeutic Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Therapeutic Product Type
Table 13. Global Hereditary Angioedema Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hereditary Angioedema Therapeutic
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Therapeutic Market Challenges
Table 22. Global Hereditary Angioedema Therapeutic Sales by Type (Kilotons)
Table 23. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 24. Global Hereditary Angioedema Therapeutic Sales (Kilotons) by Type (2019-2024)
Table 25. Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2019-2024)
Table 26. Global Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2019-2024)
Table 27. Global Hereditary Angioedema Therapeutic Market Size Share by Type (2019-2024)
Table 28. Global Hereditary Angioedema Therapeutic Price (USD/Ton) by Type (2019-2024)
Table 29. Global Hereditary Angioedema Therapeutic Sales (Kilotons) by Application
Table 30. Global Hereditary Angioedema Therapeutic Market Size by Application
Table 31. Global Hereditary Angioedema Therapeutic Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2019-2024)
Table 33. Global Hereditary Angioedema Therapeutic Sales by Application (2019-2024) & (M USD)
Table 34. Global Hereditary Angioedema Therapeutic Market Share by Application (2019-2024)
Table 35. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2024)
Table 36. Global Hereditary Angioedema Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2019-2024)
Table 38. North America Hereditary Angioedema Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Hereditary Angioedema Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Hereditary Angioedema Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Hereditary Angioedema Therapeutic Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region (2019-2024) & (Kilotons)
Table 43. BioCryst Pharma Hereditary Angioedema Therapeutic Basic Information
Table 44. BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
Table 45. BioCryst Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. BioCryst Pharma Business Overview
Table 47. BioCryst Pharma Hereditary Angioedema Therapeutic SWOT Analysis
Table 48. BioCryst Pharma Recent Developments
Table 49. Ionis Pharma Hereditary Angioedema Therapeutic Basic Information
Table 50. Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
Table 51. Ionis Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ionis Pharma Business Overview
Table 53. Ionis Pharma Hereditary Angioedema Therapeutic SWOT Analysis
Table 54. Ionis Pharma Recent Developments
Table 55. Pharming Group Hereditary Angioedema Therapeutic Basic Information
Table 56. Pharming Group Hereditary Angioedema Therapeutic Product Overview
Table 57. Pharming Group Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Pharming Group Hereditary Angioedema Therapeutic SWOT Analysis
Table 59. Pharming Group Business Overview
Table 60. Pharming Group Recent Developments
Table 61. CSL Limited Hereditary Angioedema Therapeutic Basic Information
Table 62. CSL Limited Hereditary Angioedema Therapeutic Product Overview
Table 63. CSL Limited Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. CSL Limited Business Overview
Table 65. CSL Limited Recent Developments
Table 66. Shire Hereditary Angioedema Therapeutic Basic Information
Table 67. Shire Hereditary Angioedema Therapeutic Product Overview
Table 68. Shire Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Shire Business Overview
Table 70. Shire Recent Developments
Table 71. Attune Pharma Hereditary Angioedema Therapeutic Basic Information
Table 72. Attune Pharma Hereditary Angioedema Therapeutic Product Overview
Table 73. Attune Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Attune Pharma Business Overview
Table 75. Attune Pharma Recent Developments
Table 76. Adverum Biotechnologies Hereditary Angioedema Therapeutic Basic Information
Table 77. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
Table 78. Adverum Biotechnologies Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Adverum Biotechnologies Business Overview
Table 80. Adverum Biotechnologies Recent Developments
Table 81. KalVista Pharma Hereditary Angioedema Therapeutic Basic Information
Table 82. KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
Table 83. KalVista Pharma Hereditary Angioedema Therapeutic Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. KalVista Pharma Business Overview
Table 85. KalVista Pharma Recent Developments
Table 86. Global Hereditary Angioedema Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Hereditary Angioedema Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Hereditary Angioedema Therapeutic Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Hereditary Angioedema Therapeutic Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Hereditary Angioedema Therapeutic Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Hereditary Angioedema Therapeutic Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Hereditary Angioedema Therapeutic Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Hereditary Angioedema Therapeutic Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Hereditary Angioedema Therapeutic Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hereditary Angioedema Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global Hereditary Angioedema Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global Hereditary Angioedema Therapeutic Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Therapeutic Market Size by Country (M USD)
Figure 11. Hereditary Angioedema Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hereditary Angioedema Therapeutic Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hereditary Angioedema Therapeutic Market Share by Type
Figure 18. Sales Market Share of Hereditary Angioedema Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of Hereditary Angioedema Therapeutic by Type in 2023
Figure 20. Market Size Share of Hereditary Angioedema Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of Hereditary Angioedema Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hereditary Angioedema Therapeutic Market Share by Application
Figure 24. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global Hereditary Angioedema Therapeutic Sales Market Share by Application in 2023
Figure 26. Global Hereditary Angioedema Therapeutic Market Share by Application (2019-2024)
Figure 27. Global Hereditary Angioedema Therapeutic Market Share by Application in 2023
Figure 28. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hereditary Angioedema Therapeutic Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hereditary Angioedema Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hereditary Angioedema Therapeutic Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hereditary Angioedema Therapeutic Sales Market Share by Region in 2023
Figure 44. China Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hereditary Angioedema Therapeutic Sales and Growth Rate (Kilotons)
Figure 50. South America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hereditary Angioedema Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hereditary Angioedema Therapeutic Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hereditary Angioedema Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hereditary Angioedema Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global Hereditary Angioedema Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Hereditary Angioedema Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Therapeutic Market Size (M USD), 2019-2030
Figure 5. Global Hereditary Angioedema Therapeutic Market Size (M USD) (2019-2030)
Figure 6. Global Hereditary Angioedema Therapeutic Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Therapeutic Market Size by Country (M USD)
Figure 11. Hereditary Angioedema Therapeutic Sales Share by Manufacturers in 2023
Figure 12. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers in 2023
Figure 13. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hereditary Angioedema Therapeutic Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Therapeutic Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hereditary Angioedema Therapeutic Market Share by Type
Figure 18. Sales Market Share of Hereditary Angioedema Therapeutic by Type (2019-2024)
Figure 19. Sales Market Share of Hereditary Angioedema Therapeutic by Type in 2023
Figure 20. Market Size Share of Hereditary Angioedema Therapeutic by Type (2019-2024)
Figure 21. Market Size Market Share of Hereditary Angioedema Therapeutic by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hereditary Angioedema Therapeutic Market Share by Application
Figure 24. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2019-2024)
Figure 25. Global Hereditary Angioedema Therapeutic Sales Market Share by Application in 2023
Figure 26. Global Hereditary Angioedema Therapeutic Market Share by Application (2019-2024)
Figure 27. Global Hereditary Angioedema Therapeutic Market Share by Application in 2023
Figure 28. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2019-2024)
Figure 30. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 32. U.S. Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Hereditary Angioedema Therapeutic Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Hereditary Angioedema Therapeutic Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 37. Germany Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Hereditary Angioedema Therapeutic Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Hereditary Angioedema Therapeutic Sales Market Share by Region in 2023
Figure 44. China Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Hereditary Angioedema Therapeutic Sales and Growth Rate (Kilotons)
Figure 50. South America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2023
Figure 51. Brazil Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Hereditary Angioedema Therapeutic Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Hereditary Angioedema Therapeutic Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Hereditary Angioedema Therapeutic Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hereditary Angioedema Therapeutic Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2025-2030)
Figure 65. Global Hereditary Angioedema Therapeutic Sales Forecast by Application (2025-2030)
Figure 66. Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2025-2030)